Literature DB >> 1422394

Treating psoriasis with calcipotriol.

P C Newbold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1422394      PMCID： PMC1883059          DOI： 10.1136/bmj.305.6858.847

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Generalised pustular psoriasis: response to topical calcipotriol.

Authors:  J Berth-Jones; J Bourke; K Bailey; R A Graham-Brown; P E Hutchinson
Journal:  BMJ       Date:  1992-10-10

2.  Topical calcipotriol and hypercalcaemia.

Authors: 
Journal:  Lancet       Date:  1991-05-25       Impact factor: 79.321

3.  Photometabolism of 7-dehydrocholesterol to previtamin D3 in skin.

Authors:  M F Holick; J E Frommer; S C McNeill; N M Richtand; J W Henley; J T Potts
Journal:  Biochem Biophys Res Commun       Date:  1977-05-09       Impact factor: 3.575

4.  An open study of vitamin D3 treatment in psoriasis vulgaris.

Authors:  S Morimoto; K Yoshikawa; T Kozuka; Y Kitano; S Imanaka; K Fukuo; E Koh; Y Kumahara
Journal:  Br J Dermatol       Date:  1986-10       Impact factor: 9.302

5.  Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903)

Authors:  K Kragballe
Journal:  Arch Dermatol       Date:  1989-12

6.  Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris.

Authors:  K Kragballe; B T Gjertsen; D De Hoop; T Karlsmark; P C van de Kerkhof; O Larkö; C Nieboer; J Roed-Petersen; A Strand; G Tikjøb
Journal:  Lancet       Date:  1991-01-26       Impact factor: 79.321

7.  A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis.

Authors:  J Berth-Jones; A C Chu; W A Dodd; M Ganpule; W A Griffiths; R P Haydey; M R Klaber; S J Murray; S Rogers; H J Jurgensen
Journal:  Br J Dermatol       Date:  1992-09       Impact factor: 9.302

8.  Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3.

Authors:  J A MacLaughlin; W Gange; D Taylor; E Smith; M F Holick
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.